Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Total Current Liabilities: 2009-2012

Historic Total Current Liabilities for Lexicon Pharmaceuticals (LXRX) over the last 4 years, with Sep 2012 value amounting to $19.1 million.

  • Lexicon Pharmaceuticals' Total Current Liabilities rose 28.67% to $19.1 million in Q3 2012 from the same period last year, while for Sep 2012 it was $19.1 million, marking a year-over-year increase of 28.67%. This contributed to the annual value of $21.4 million for FY2011, which is 98.52% up from last year.
  • As of Q3 2012, Lexicon Pharmaceuticals' Total Current Liabilities stood at $19.1 million, which was down 11.62% from $21.6 million recorded in Q2 2012.
  • Lexicon Pharmaceuticals' Total Current Liabilities' 5-year high stood at $51.0 million during Q4 2009, with a 5-year trough of $10.8 million in Q4 2010.
  • Over the past 3 years, Lexicon Pharmaceuticals' median Total Current Liabilities value was $19.1 million (recorded in 2012), while the average stood at $20.4 million.
  • The largest annual percentage gain for Lexicon Pharmaceuticals' Total Current Liabilities in the last 5 years was 285.25% (2010), contrasted with its biggest fall of 78.85% (2010).
  • Over the past 4 years, Lexicon Pharmaceuticals' Total Current Liabilities (Quarterly) stood at $51.0 million in 2009, then tumbled by 78.85% to $10.8 million in 2010, then spiked by 98.52% to $21.4 million in 2011, then climbed by 28.67% to $19.1 million in 2012.
  • Its Total Current Liabilities was $19.1 million in Q3 2012, compared to $21.6 million in Q2 2012 and $20.9 million in Q1 2012.